Table 3.
Selected HIV-related characteristics of HIV positive patients with PCNSL
Characteristics | n+/n (%) |
---|---|
HAART at diagnosis | 13/37 (35) |
HAART added after PCNSL diagnosis | 17/24 (71) |
CD4 at diagnosis of PCNSL < 200 | 33/35 (92) |
CD4 at diagnosis of PCNSL < 50 | 23/35 (66) |
CD4 at PCNSLa | 56 ± 14 (2-374) |
CD4 at HIV diagnosisa | 75 ± 13 (2-247) |
Interval between HIV and PCNSL diagnoses (mos)a | 55.2 ± 8.8 (0-184.9) |
Mean ± SE (range)
HAART highly-active antiretroviral treatment, PCNSL primary CNS lymphoma